Peer Review reports
From: Enhanced cytotoxic effect of doxorubicin conjugated gold nanoparticles on breast cancer model
| Original Submission | ||
|---|---|---|
| 29 Jun 2022 | Submitted | Original manuscript |
| Resubmission - Version 2 | ||
| Submitted | Manuscript version 2 | |
| 19 Jul 2022 | Reviewed | Reviewer Report |
| 14 Sep 2022 | Reviewed | Reviewer Report |
| 28 Sep 2022 | Author responded | Author comments - Amna H. Faid |
| Resubmission - Version 3 | ||
| 28 Sep 2022 | Submitted | Manuscript version 3 |
| 5 Oct 2022 | Author responded | Author comments - Amna H. Faid |
| Resubmission - Version 4 | ||
| 5 Oct 2022 | Submitted | Manuscript version 4 |
| 7 Oct 2022 | Author responded | Author comments - Amna H. Faid |
| Resubmission - Version 5 | ||
| 7 Oct 2022 | Submitted | Manuscript version 5 |
| 18 Oct 2022 | Reviewed | Reviewer Report |
| 28 Oct 2022 | Reviewed | Reviewer Report |
| Resubmission - Version 6 | ||
| Submitted | Manuscript version 6 | |
| Publishing | ||
| 29 Oct 2022 | Editorially accepted | |
| 9 Nov 2022 | Article published | 10.1186/s13065-022-00889-9 |
You can find further information about peer review here.